Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Prelude Therapeutics Q3 EPS $(0.63) Up From $(0.66) YoY

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.63) per share. This is a 4.55 percent increase over losses of $(0.66) per share from the same period last year.
byBenzinga Newsdesk
November 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.63) per share. This is a 4.55 percent increase over losses of $(0.66) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts